Editor

The French riots get worse and Abdul Al-Sayed's Muslim Brotherhood controversy.

We'll discuss all this and more on this edition of the editors.

I'm Rich Lowry.

I'm joined as always by the right honorable Charles C.W. Cook, the sage of authenticity, which Jim Garrity and the notorious M.B. D, Michael Brennan Doherty.

It has to be a continuing, evolving project and culture.

But he said that about the French language, which I think could be a non-starter for much – French people.

But anyway, if you are French and offended by what Charlie just said, we'd love to hear from you at our email, editorspod at nationalreview.com, and love to hear from anyone else as well.

Next question to you first, MBD.

Thank you, Chris, for discussing all things ESICM with us today.

We look forward to having you back on the Editor's Summary again very soon.

Thanks for having me.

[outro music]

This study gives a window into how quickly AI-based tools have entered clinical work and what clinicians are asking them to do.

JAMA also published an editor's note accompanying this study.

Kirsten, you and JAMA Associate Editor Dr. Kara and JAMA Deputy Editor Dr. Ross say the findings of this study document sustained engagement with AI-enabled clinical information tools, not just experimentation.

You also emphasize an important caution.

Can cash incentives help underserved patients quit smoking? Is a more intensive approach to advance care planning beneficial? Which occupations face the highest rates of heat-related deaths in the U.S.? This and much more on today's JAMA Editor Summary.

Hello, and welcome to our listeners around the world.

Today is Friday, October 9th, 2026.

I'm Dr. Kirsten Bibbins-Domingo, Editor-in-Chief of JAMA and the JAMA Network.

Today, I'm joined by Dr. Preeti Malani, JAMA Deputy Editor.

Let's get started with a new research article about smoking cessation in medically underserved adults, referred for lung cancer screening.

Cigarette smoking remains the leading cause of preventable morbidity and mortality worldwide.

From trends in autism diagnosis to private equity acquisition to AI and much, much more, visit jamanetworkaudio.com or search Healthy Dialogue wherever you get your podcasts to subscribe.

For critically ill children, can clinicians safely target a lower blood pressure? After a successful thrombectomy, should thrombolytics be used? What are the latest trends in GLP-1 use after pregnancy? This and much more on today's JAMA Editor Summary.

Welcome to our listeners all around the world.

Today is Friday, October 2nd, 2026.

I'm Dr. Linda Brubaker, JAMA Deputy Editor.

Today I'm joined by JAMA Deputy Editor, Dr. Preeti Malani.

Hey Preeti, let's start with the new research that addresses a common question in the pediatric ICU.

What's the optimal blood pressure target for pediatric patients on vasopressors? Thanks,

[Instrumental music] Hello.

Welcome to The Editor's Desk.

This is the podcast where we take a closer look at the essays and articles in the latest print issue of First Things Magazine.

I'm Rusty Reno.

I'm the editor of First Things Magazine, and I'm here with you today At The Editor's Desk.

[Instrumental music] I'd like to welcome my colleague Dan Hitchens, senior editor here at First Things Magazine, and we're gonna talk about his essay in the October issue, "The Making of Roger Scruton." Welcome to the podcast, Dan.

Nice to be here.

From trends in autism diagnosis to private equity acquisition to AI and much, much more, visit jamanetworkaudio.com or search Healthy Dialogue wherever you get your podcasts to subscribe.

Could Medicare Advantage impact access to kidney transplant? For patients who present four and a half to 24 hours after basal artery stroke, does tenecteplase before thrombectomy help? What are the current trends in polypharmacy among older adults? And what should clinicians know about vaccines for cancer? This and so much more on today's JAMA Editor Summary.

Welcome to our listeners all around the world.

Today is Friday, September 25th, 2026.

I'm Dr. Linda Brubaker, JAMA Deputy Editor.

And today I'm joined by Dr. Preeti Malani, JAMA Deputy Editor.

Let's get started with the study on kidney transplant excess.

More than 500,000 people in the United States are on maintenance dialysis to treat kidney failure.